Continuous noninvasive in vivo monitoring of intravascular plasma volume and hematocrit changes during hemodialysis in humans

Direct comparison with the CRIT-LINE

Bin Deng, Evan Kastner, Sriram S. Narsipur, Jerry Goodisman, Joseph Chaiken

Research output: Chapter in Book/Report/Conference proceedingConference contribution

5 Citations (Scopus)

Abstract

We report a new device and algorithm that allows simultaneous monitoring of the hematocrit and plasma volume fraction of blood within the intravascular space of an optically probed volume of skin. Skin is probed with a near infrared (NIR) laser and simultaneously collecting the Rayleigh and Mie scattered light as one raw signal and the undifferentiated Raman and fluorescence emission as the second raw signal. These signals are combined using six parameters that can be obtained by either direct calculation or empirical calibration to permit monitoring of the blood in human skin (e.g. fingertips). We tested a device based on the algorithm that might be useful in allowing the early detection of blood loss for people who have no external injury but may be hemorrhaging internally. IRB allowed experiments monitoring blood in human fingertip skin in vivo during routine hemodialysis demonstrated good agreement between the experimental device and the CRIT-LINE®, an FDA approved device that is built into the dialysis machine and applies the Twersky algorithm to blood in the dialysis machine (i.e. in vitro). Based on observation of 9 different test subjects, as dialysis removes fluid from the intravascular space causing an increase in hematocrit and a decrease in plasma volume, the CRIT-LINE response is closely emulated (typical per session linear correlation r2=0.78, N=87, p<0.0001) with the new device. Calibration across subjects, the measurement of absolute hematocrit, and potential confounding factors will also be discussed.

Original languageEnglish (US)
Title of host publicationProgress in Biomedical Optics and Imaging - Proceedings of SPIE
PublisherSPIE
Volume8935
ISBN (Print)9780819498489
DOIs
StatePublished - 2014
EventAdvanced Biomedical and Clinical Diagnostic and Surgical Guidance Systems XII - San Francisco, CA, United States
Duration: Feb 2 2014Feb 4 2014

Other

OtherAdvanced Biomedical and Clinical Diagnostic and Surgical Guidance Systems XII
CountryUnited States
CitySan Francisco, CA
Period2/2/142/4/14

Fingerprint

hematocrit
Plasma Volume
Hematocrit
blood
Renal Dialysis
Blood
dialysis
Dialysis
Skin
Plasmas
Equipment and Supplies
Monitoring
Calibration
Infrared lasers
Research Ethics Committees
infrared lasers
Volume fraction
Lasers
Fluorescence
Observation

Keywords

  • CRIT-LINE
  • Dialysis
  • Hematocrit
  • Hemorrhage
  • In vivo
  • Noninvasive
  • Plasma volume

ASJC Scopus subject areas

  • Atomic and Molecular Physics, and Optics
  • Electronic, Optical and Magnetic Materials
  • Biomaterials
  • Radiology Nuclear Medicine and imaging

Cite this

Deng, B., Kastner, E., Narsipur, S. S., Goodisman, J., & Chaiken, J. (2014). Continuous noninvasive in vivo monitoring of intravascular plasma volume and hematocrit changes during hemodialysis in humans: Direct comparison with the CRIT-LINE. In Progress in Biomedical Optics and Imaging - Proceedings of SPIE (Vol. 8935). [89351N] SPIE. https://doi.org/10.1117/12.2043989

Continuous noninvasive in vivo monitoring of intravascular plasma volume and hematocrit changes during hemodialysis in humans : Direct comparison with the CRIT-LINE. / Deng, Bin; Kastner, Evan; Narsipur, Sriram S.; Goodisman, Jerry; Chaiken, Joseph.

Progress in Biomedical Optics and Imaging - Proceedings of SPIE. Vol. 8935 SPIE, 2014. 89351N.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Deng, B, Kastner, E, Narsipur, SS, Goodisman, J & Chaiken, J 2014, Continuous noninvasive in vivo monitoring of intravascular plasma volume and hematocrit changes during hemodialysis in humans: Direct comparison with the CRIT-LINE. in Progress in Biomedical Optics and Imaging - Proceedings of SPIE. vol. 8935, 89351N, SPIE, Advanced Biomedical and Clinical Diagnostic and Surgical Guidance Systems XII, San Francisco, CA, United States, 2/2/14. https://doi.org/10.1117/12.2043989
Deng B, Kastner E, Narsipur SS, Goodisman J, Chaiken J. Continuous noninvasive in vivo monitoring of intravascular plasma volume and hematocrit changes during hemodialysis in humans: Direct comparison with the CRIT-LINE. In Progress in Biomedical Optics and Imaging - Proceedings of SPIE. Vol. 8935. SPIE. 2014. 89351N https://doi.org/10.1117/12.2043989
Deng, Bin ; Kastner, Evan ; Narsipur, Sriram S. ; Goodisman, Jerry ; Chaiken, Joseph. / Continuous noninvasive in vivo monitoring of intravascular plasma volume and hematocrit changes during hemodialysis in humans : Direct comparison with the CRIT-LINE. Progress in Biomedical Optics and Imaging - Proceedings of SPIE. Vol. 8935 SPIE, 2014.
@inproceedings{bde74be6228b4274b16043c81e4c80a5,
title = "Continuous noninvasive in vivo monitoring of intravascular plasma volume and hematocrit changes during hemodialysis in humans: Direct comparison with the CRIT-LINE",
abstract = "We report a new device and algorithm that allows simultaneous monitoring of the hematocrit and plasma volume fraction of blood within the intravascular space of an optically probed volume of skin. Skin is probed with a near infrared (NIR) laser and simultaneously collecting the Rayleigh and Mie scattered light as one raw signal and the undifferentiated Raman and fluorescence emission as the second raw signal. These signals are combined using six parameters that can be obtained by either direct calculation or empirical calibration to permit monitoring of the blood in human skin (e.g. fingertips). We tested a device based on the algorithm that might be useful in allowing the early detection of blood loss for people who have no external injury but may be hemorrhaging internally. IRB allowed experiments monitoring blood in human fingertip skin in vivo during routine hemodialysis demonstrated good agreement between the experimental device and the CRIT-LINE{\circledR}, an FDA approved device that is built into the dialysis machine and applies the Twersky algorithm to blood in the dialysis machine (i.e. in vitro). Based on observation of 9 different test subjects, as dialysis removes fluid from the intravascular space causing an increase in hematocrit and a decrease in plasma volume, the CRIT-LINE response is closely emulated (typical per session linear correlation r2=0.78, N=87, p<0.0001) with the new device. Calibration across subjects, the measurement of absolute hematocrit, and potential confounding factors will also be discussed.",
keywords = "CRIT-LINE, Dialysis, Hematocrit, Hemorrhage, In vivo, Noninvasive, Plasma volume",
author = "Bin Deng and Evan Kastner and Narsipur, {Sriram S.} and Jerry Goodisman and Joseph Chaiken",
year = "2014",
doi = "10.1117/12.2043989",
language = "English (US)",
isbn = "9780819498489",
volume = "8935",
booktitle = "Progress in Biomedical Optics and Imaging - Proceedings of SPIE",
publisher = "SPIE",

}

TY - GEN

T1 - Continuous noninvasive in vivo monitoring of intravascular plasma volume and hematocrit changes during hemodialysis in humans

T2 - Direct comparison with the CRIT-LINE

AU - Deng, Bin

AU - Kastner, Evan

AU - Narsipur, Sriram S.

AU - Goodisman, Jerry

AU - Chaiken, Joseph

PY - 2014

Y1 - 2014

N2 - We report a new device and algorithm that allows simultaneous monitoring of the hematocrit and plasma volume fraction of blood within the intravascular space of an optically probed volume of skin. Skin is probed with a near infrared (NIR) laser and simultaneously collecting the Rayleigh and Mie scattered light as one raw signal and the undifferentiated Raman and fluorescence emission as the second raw signal. These signals are combined using six parameters that can be obtained by either direct calculation or empirical calibration to permit monitoring of the blood in human skin (e.g. fingertips). We tested a device based on the algorithm that might be useful in allowing the early detection of blood loss for people who have no external injury but may be hemorrhaging internally. IRB allowed experiments monitoring blood in human fingertip skin in vivo during routine hemodialysis demonstrated good agreement between the experimental device and the CRIT-LINE®, an FDA approved device that is built into the dialysis machine and applies the Twersky algorithm to blood in the dialysis machine (i.e. in vitro). Based on observation of 9 different test subjects, as dialysis removes fluid from the intravascular space causing an increase in hematocrit and a decrease in plasma volume, the CRIT-LINE response is closely emulated (typical per session linear correlation r2=0.78, N=87, p<0.0001) with the new device. Calibration across subjects, the measurement of absolute hematocrit, and potential confounding factors will also be discussed.

AB - We report a new device and algorithm that allows simultaneous monitoring of the hematocrit and plasma volume fraction of blood within the intravascular space of an optically probed volume of skin. Skin is probed with a near infrared (NIR) laser and simultaneously collecting the Rayleigh and Mie scattered light as one raw signal and the undifferentiated Raman and fluorescence emission as the second raw signal. These signals are combined using six parameters that can be obtained by either direct calculation or empirical calibration to permit monitoring of the blood in human skin (e.g. fingertips). We tested a device based on the algorithm that might be useful in allowing the early detection of blood loss for people who have no external injury but may be hemorrhaging internally. IRB allowed experiments monitoring blood in human fingertip skin in vivo during routine hemodialysis demonstrated good agreement between the experimental device and the CRIT-LINE®, an FDA approved device that is built into the dialysis machine and applies the Twersky algorithm to blood in the dialysis machine (i.e. in vitro). Based on observation of 9 different test subjects, as dialysis removes fluid from the intravascular space causing an increase in hematocrit and a decrease in plasma volume, the CRIT-LINE response is closely emulated (typical per session linear correlation r2=0.78, N=87, p<0.0001) with the new device. Calibration across subjects, the measurement of absolute hematocrit, and potential confounding factors will also be discussed.

KW - CRIT-LINE

KW - Dialysis

KW - Hematocrit

KW - Hemorrhage

KW - In vivo

KW - Noninvasive

KW - Plasma volume

UR - http://www.scopus.com/inward/record.url?scp=84896915619&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896915619&partnerID=8YFLogxK

U2 - 10.1117/12.2043989

DO - 10.1117/12.2043989

M3 - Conference contribution

SN - 9780819498489

VL - 8935

BT - Progress in Biomedical Optics and Imaging - Proceedings of SPIE

PB - SPIE

ER -